Skip to content

Insider · CIK 0001583903

James DArecca

cfoofficerdirector

Files at HAE (HAEMONETICS CORP), PBH (Prestige Consumer Healthcare Inc.). First filing -, latest -.

Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 0
$0 bought, $0 sold

Signals

This insider’s open-market buys and sells, scored.

No scored open-market trades yet.

Transactions

Every row this insider has filed, newest first.

DateCompanyTransactionSharesPriceValueHoldings afterFiled
Aug 5, 2025PBH
Prestige Consumer Healthcare Inc.
AGrant or award
Common Stock, par value $0.01 per share
+2,094$0.00$06,591Aug 6, 2025
May 30, 2025HAE
HAEMONETICS CORP
AGrant or award
Common Stock
+12,221$0.00$034,156Jun 3, 2025
May 30, 2025HAE
HAEMONETICS CORP
FTax withholding
Common Stock
-5,864$69.38$407k28,292Jun 3, 2025
May 16, 2025HAE
HAEMONETICS CORP
AGrant or award
Common Stock
+7,111--21,935May 20, 2025
May 16, 2025HAE
HAEMONETICS CORP
AGrant or award
Non-qualified Stock Option (Right to Buy)derivative
+15,396$0.00$015,396May 20, 2025
May 15, 2025HAE
HAEMONETICS CORP
FTax withholding
Common Stock
-622$69.38$43k16,070May 19, 2025
May 16, 2025HAE
HAEMONETICS CORP
FTax withholding
Common Stock
-1,246$70.31$88k14,824May 19, 2025
May 2, 2025HAE
HAEMONETICS CORP
FTax withholding
Common Stock
-654$63.85$42k16,692May 5, 2025

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

James DArecca: insider trades and track record | InsiderTell